AzTrials
AzTrials

Airway ManagementVieScOPNCT04724408

VieScope Versus Direct Laryngoscopic Intubation

A study testing VieScope and Conventional in people with Airway Management, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients requiring endotracheal intubation for elective surgery without expected difficult airway are randomized to be intubated either by a) VieScope or b) conventional direct laryngoscopy. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Airway Management
What is being tested?
VieScope and Conventional
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteGermany
Study dates
26 Jan 2021to 1 Mar 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients requiring general anesthesia with transoral tracheal intubation for elective surgery
  • Age ≥ 18
  • Preoperative airway assessment reveals an expected non-difficult airway (rated by the responsible anesthetist in the Pre-assessment Clinic based on the existing in-house algorithm)

Who cannot join

  • Pregnant or breastfeeding woman
  • Confirmed indications for awake fiberoptic intubation especially due to enoral, pharyngeal tumors, abscesses or other processes
  • Planned endotracheal intubation without deep anesthesia or neuromuscular blocking agents (e.g. awake videolaryngoscopy)
  • Required transnasal tracheal intubation (e.g. for surgical reasons)
  • Requirement of special endotracheal tubes such as laser or RAE tubes for surgical reasons
  • Patients at risk for pulmonary aspiration who qualify for rapid sequence induction
  • Loose teeth
  • Denial of consent

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Universitätsklinikum Hamburg-Eppendorf

    Hamburg, Free and Hanseatic City of Hamburg, 20246

Other trials in Germany

About this study

Official title: Endotracheal Intubation With VieScope Versus Direct Laryngoscopic Intubation in Patients for Elective Surgery - a Prospective Randomized Trial.

Patients requiring endotracheal intubation for elective surgery without expected difficult airway are randomized to be intubated either by a) VieScope or b) conventional direct laryngoscopy.

Read the detailed description

Endotracheal intubation is required for different surgical procedures for mechanical ventilation and to prevent aspiration of secretions. Endotracheal intubation is usually performed by direct laryngoscopy (DL), i.e. during otorhinolaryngologic or oral and maxillofacial surgery. This technique has limitations and may fail due to insufficient visualization of the larynx. A new device has been introduced that consists of an illuminated straight plastic tube for laryngoscopy (VSC, Vie Scope, Adroit Surgical, Oklahoma City, OK, USA) that enables for indirect intubation over a stylet. So far, the VSC has shown promising results in manikin studies for intubation in normal and difficult airways and was shown to be superior over conventional laryngoscopy during cardiopulmonary resuscitation with providers wearing personal protective equipment. Data in elective patients undergoing otorhinolaryngologic or oral and maxillofacial surgery are not available, so far.

Therefore, we aim to test the VSC in patients compared to conventional techniques in a prospective randomized non-inferiority trial. We aim to test the VSC in predicted non-difficult airway patients.

Patients will be assessed for eligibility in the Anesthesiology Pre-assessment Clinic of the University Medical Center Hamburg-Eppendorf prior to elective surgery. To rule out a difficult airway prior to study inclusion, all patients receive a structured preoperative airway assessment in accordance with standard operating procedure of the Department of Anesthesiology, University Medical Center Hamburg-Eppendorf using the implemented in-house algorithm for the prediction of difficult airway management and the Simplified Airway Risk Index (SARI).

Patients are randomized 1:1 to either intervention or control group. Patients randomized to the intervention group will be intubated with the VSC. Patients randomized to the control group are intubated with a standard MacIntosh type laryngoscope by DL. Anesthesia management, the choice of the blade and tube size, as well as the use of adjuncts like stylets, introducers or forceps or airway optimization maneuvers (e.g. backward upward rightward pressure [BURP] and optimum external laryngeal manipulation [OELM]) will be left to the discretion of the attending physician.

Based on a first attempt success rate of 40%, and a noninferiority margin of 5%, 2x 29 patients are required with errors of α=0.025 and β=0.2 to show non-inferiority for the intervention method (PASS version 08.0.6, NCSS, LLC. Kaysville, UT, USA).

All participating physicians are anesthesiology residents or fellows. To avoid a bias that may occur due to different skills for VSC compared to conventional laryngoscopy, physicians participating in this study take part in a 30 min structured manikin airway training before participating in this study. The age and months of work experience of the participating anesthetists will be assessed within a questionnaire.

Being tested
VieScope, Conventional

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VieScopeDevice

    see above

  • ConventionalDevice

    see above

Study groups in NCT04724408
Study groupRoleWhat they receive
VieScopeExperimentalintubation with the VieScope laryngoscope
Receives: Device: VieScope
ConventionalActive comparatorintubation with MacIntosh-type laryngoscope
Receives: Device: Conventional

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First attempt success rate

    percentage of successful intubations with one attempt

    Measured: 15 min

Secondary outcomes (11)
  1. intubating conditions

    grades according to Cormack-Lehane and POGO

    Measured: 15 min

  2. overall success rate

    percentage of successful intubations with the allocated procedure

    Measured: 15 min

  3. time to successful intubation

    time until an endotracheal airway access is established

    Measured: 15 min

  4. time to successful intubation with one attempt

    time until an endotracheal airway access is established in patients that are intubated at first attempt

    Measured: 15 min

  5. intubation difficulty

    subjective rating on a visual analogue scale (0-100, higher values indicate more difficult intubation) of the difficulty of airway management and questionnaire

    Measured: 15 min

  6. end-tidal carbondioxide fraction

    the highest end-tidal carbondioxide fraction in the exspiratory gas within two minutes after successful intubation

    Measured: 15 min

  7. number of attempts

    total number of attempts until airway established

    Measured: 15 min

  8. aspiration

    percentage of patients that vomit and aspirate during intubation

    Measured: 15 min

  9. esophageal intubation

    percentage of accidental esophageal intubation attempts

    Measured: 15 min

  10. hypoxia

    percentage of patients with a desaturation below a pulsoximetric saturation of 80%

    Measured: 15 min

  11. hypotension

    percentage of patients with a systolic blood pressure below 70 mmHg

    Measured: 15 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2021
  2. Study start26 Jan 2021
  3. Primary completion1 Mar 2021
  4. Study completion1 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized 1:1
Masking
Single blind
Who is masked
Participant
Enrolment
58 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04724408
Sponsor's protocol ID
VieScOP
Acronym
VieScOP
Status last verified
Apr 2021
First submitted
23 Jan 2021
Last updated
8 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing VieScope and Conventional in people with Airway Management, run by Universitätsklinikum Hamburg-Eppendorf at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First attempt success rate (time frame: 15 min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in